This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003; 148:293–300.DiezJJIglesiasPThe role of the novel adipocyte-derived hormone adiponectin in human disease200314829330010.1530/eje.0.148029312611609Search in Google Scholar
Kim HY, Bae EH, Ma SK, Chae DW, Choi KH, Kim Y-S, et al. Association of serum adiponectin level with albuminuria in chronic kidney disease patients. Clin Exp Nephrol. 2016; 20:443–9.KimHYBaeEHMaSKChaeDWChoiKHKimY-Set alAssociation of serum adiponectin level with albuminuria in chronic kidney disease patients201620443910.1007/s10157-015-1173-426445954Search in Google Scholar
Sweiss N, Sharma K. Adiponectin effects on the kidney. Best Pract Res Clin Endocrinol Metab. 2014; 28:71–9.SweissNSharmaKAdiponectin effects on the kidney20142871910.1016/j.beem.2013.08.002425256724417947Search in Google Scholar
Tungtrongchitr R, Sricharoen P, Pongpaew P, Phonrat B, Arthan D, Vudhivai N, et al. Adiponectin/ACP30, a collagen-like plasma protein in relation to anthropometric measurement in Thai overweight and obese subjects. Int J Food Sci Nutr. 2005; 56:193–201.TungtrongchitrRSricharoenPPongpaewPPhonratBArthanDVudhivaiNet alAdiponectin/ACP30, a collagen-like plasma protein in relation to anthropometric measurement in Thai overweight and obese subjects20055619320110.1080/0963748050015411316009634Search in Google Scholar
Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obesity. 2002; 10:1104–10.YangWSLeeWJFunahashiTTanakaSMatsuzawaYChaoCLet alPlasma adiponectin levels in overweight and obese Asians20021011041010.1038/oby.2002.15012429873Search in Google Scholar
Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014; 2014:1–14.NigroEScudieroOMonacoMLPalmieriAMazzarellaGCostagliolaCet alNew insight into adiponectin role in obesity and obesity-related diseases2014201411410.1155/2014/658913410942425110685Search in Google Scholar
Aleidi S, Issa A, Bustanji H, Khalil M, Bustanji Y. Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm J. 2015; 23:250–6.AleidiSIssaABustanjiHKhalilMBustanjiYAdiponectin serum levels correlate with insulin resistance in type 2 diabetic patients201523250610.1016/j.jsps.2014.11.011447581326106273Search in Google Scholar
Blaslov K, Bulum T, Zibar K, Duvnjak L. Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients. Int J Endocrinol. 2013; 2013:1–6.BlaslovKBulumTZibarKDuvnjakLRelationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients201320131610.1155/2013/535906373022523956744Search in Google Scholar
Shibata R, Ouchi N, Murohara T. Adiponectin and cardiovascular disease. Circ J. 2009; 73:608–14.ShibataROuchiNMuroharaTAdiponectin and cardiovascular disease2009736081410.1253/circj.CJ-09-005719261992Search in Google Scholar
Siasos G, Tousoulis D, Kollia C, Oikonomou E, Siasou Z, Stefanadis C, et al. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches. Curr Med Chem. 2012; 19:1193–209.SiasosGTousoulisDKolliaCOikonomouESiasouZStefanadisCet alAdiponectin and cardiovascular disease: mechanisms and new therapeutic approaches201219119320910.2174/09298671279932058322257055Search in Google Scholar
Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17:2599–606.MenonVLiLWangXGreeneTBalakrishnanVMaderoMet alAdiponectin and mortality in patients with chronic kidney disease200617259960610.1681/ASN.2006040331Search in Google Scholar
Kamimura MA, Canziani MEF, Sanches FR, Velludo CM, Carrero JJ, Bazanelli AP, et al. Variations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months. J Bras Nefrol. 2012; 34:259–65.KamimuraMACanzianiMEFSanchesFRVelludoCMCarreroJJBazanelliAPet alVariations in adiponectin levels in patients with chronic kidney disease: a prospective study of 12 months2012342596510.5935/0101-2800.20120007Search in Google Scholar
Saginova E, Galliamov M, Severova M, Surkova O, Fomin V, Ermakov N, et al. The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients. Ter Arkh. 2011; 83:47–53.SaginovaEGalliamovMSeverovaMSurkovaOFominVErmakovNet alThe role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients2011834753Search in Google Scholar
Sedighi O, Abediankenari S. Relationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease. Nephrourol Mon. 2014; 6:1–4.SedighiOAbediankenariSRelationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease201461410.5812/numonthly.11743Search in Google Scholar
Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW. Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant. 2006; 22:171–8.ShenYYCharlesworthJAKellyJJLoiKWPeakePWUp-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease200622171810.1093/ndt/gfl552Search in Google Scholar
James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010; 375:1296–309.JamesMTHemmelgarnBRTonelliMEarly recognition and prevention of chronic kidney disease2010375129630910.1016/S0140-6736(09)62004-3Search in Google Scholar
Decreased G. Definition and classification of CKD. Kidney Int. 2013; 3:19–62.DecreasedGDefinition and classification of CKD20133196210.1038/kisup.2012.64408969325018975Search in Google Scholar
Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67:2089–100.LeveyASEckardtK-UTsukamotoYLevinACoreshJRossertJet alDefinition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO)200567208910010.1111/j.1523-1755.2005.00365.x15882252Search in Google Scholar
Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015; 313:837–46.LeveyASBeckerCInkerLAGlomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review20153138374610.1001/jama.2015.0602441036325710660Search in Google Scholar
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014; 63:713–35.InkerLAAstorBCFoxCHIsakovaTLashJPPeraltaCAet alKDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD2014637133510.1053/j.ajkd.2014.01.41624647050Search in Google Scholar
Collins AJ, Foley RN, Gilbertson DT, Chen S-C. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009; 4:5–11.CollinsAJFoleyRNGilbertsonDTChenS-CThe state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis2009451110.2215/CJN.0598080919996006Search in Google Scholar
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013; 3(Suppl):1–150.Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO2012Clinical Practice Guideline for the evaluation and management of chronic kidney disease20133Suppl1150Search in Google Scholar
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604–12.LeveyASStevensLASchmidCHZhangYLCastroAFFeldmanHIet alA new equation to estimate glomerular filtration rate20091506041210.7326/0003-4819-150-9-200905050-00006276356419414839Search in Google Scholar
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367:20–9.InkerLASchmidCHTighiouartHEckfeldtJHFeldmanHIGreeneTet alEstimating glomerular filtration rate from serum creatinine and cystatin C201236720910.1056/NEJMoa1114248439802322762315Search in Google Scholar
World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:1–253.World Health OrganizationObesity: preventing and managing the global epidemic: report of a WHO consultation20008941253Search in Google Scholar
Perri A, Vizza D, Lofaro D, Gigliotti P, Leone F, Brunelli E, et al. Adiponectin is expressed and secreted by renal tubular epithelial cells. J Nephrol. 2013; 26:1049–54.PerriAVizzaDLofaroDGigliottiPLeoneFBrunelliEet alAdiponectin is expressed and secreted by renal tubular epithelial cells20132610495410.5301/jn.500026923553527Search in Google Scholar
Wolfson N, Gavish D, Matas Z, Boaz M, Shargorodsky M. Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load. Exp Diabetes Res. 2012; 2012:1–5.WolfsonNGavishDMatasZBoazMShargorodskyMRelation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load201220121510.1155/2012/250621325510622253614Search in Google Scholar
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26:3160–7.GenuthSAlbertiKGBennettPBuseJDefronzoRKahnRet alFollow-up report on the diagnosis of diabetes mellitus2003263160710.2337/diacare.26.11.316014578255Search in Google Scholar
Briffa JF, McAinch AJ, Poronnik P, Hryciw DH. Adipokines as a link between obesity and chronic kidney disease. Am J Physiol Renal Physiol. 2013; 305:1629–36.BriffaJFMcAinchAJPoronnikPHryciwDHAdipokines as a link between obesity and chronic kidney disease201330516293610.1152/ajprenal.00263.201324107418Search in Google Scholar
Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol. 2010; 21:406–12.IxJHSharmaKMechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK2010214061210.1681/ASN.2009080820447325420150538Search in Google Scholar
Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003; 41:625–33.HallJEThe kidney, hypertension, and obesity2003416253310.1161/01.HYP.0000052314.95497.7812623970Search in Google Scholar
Eglit T, Lember M, Ringmets I, Rajasalu T. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome. Eur J Endocrinol. 2013; 168:385–91.EglitTLemberMRingmetsIRajasaluTGender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome20131683859110.1530/EJE-12-068823230211Search in Google Scholar
Cnop M, Havel P, Utzschneider K, Carr D, Sinha M, Boyko E, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46:459–69.CnopMHavelPUtzschneiderKCarrDSinhaMBoykoEet alRelationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex2003464596910.1007/s00125-003-1074-z12687327Search in Google Scholar
Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002; 51:2734–41.NishizawaHShimomuraIKishidaKMaedaNKuriyamaHNagaretaniHet alAndrogens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein20025127344110.2337/diabetes.51.9.273412196466Search in Google Scholar
Mamaghani F, Zarghami N, Maleki M, Pourhassan MM, Hosseinpanah F. Variation of adiponectin levels in normal and obese subjects: possible correlation with lipid profiles. Int J Endocrinal Metab. 2009; 3:170–8.MamaghaniFZarghamiNMalekiMPourhassanMMHosseinpanahFVariation of adiponectin levels in normal and obese subjects: possible correlation with lipid profiles200931708Search in Google Scholar
Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S, Emoto M, et al. Altered relationship between body fat and plasma adiponectin in end-stage renal disease. Metab Clin Exp. 2005; 54:330–4.ShojiTShinoharaKHatsudaSKimotoEFukumotoSEmotoMet alAltered relationship between body fat and plasma adiponectin in end-stage renal disease200554330410.1016/j.metabol.2004.09.01215736110Search in Google Scholar
Obata Y, Yamada Y, Takahi Y, Baden MY, Saisho K, Tamba S, et al. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocrinol. 2013; 79:204–10.ObataYYamadaYTakahiYBadenMYSaishoKTambaSet alRelationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes2013792041010.1111/cen.1204122963459Search in Google Scholar
Christou GA, Tellis K, Elisaf M, Tselepis AD, Kiortsis DN. High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment. Hormones. 2012; 11:178.ChristouGATellisKElisafMTselepisADKiortsisDNHigh density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment20121117810.14310/horm.2002.134522801564Search in Google Scholar
Tedla F, Brar A, Browne R, Brown C. Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens. 2011; 2011:1–9.TedlaFBrarABrowneRBrownCHypertension in chronic kidney disease: navigating the evidence201120111910.4061/2011/132405312425421747971Search in Google Scholar
Monhart V. Hypertension and chronic kidney diseases. Cor Vasa. 2013; 55:397–402.MonhartVHypertension and chronic kidney diseases20135539740210.1016/j.crvasa.2013.07.006Search in Google Scholar